Related Experiment Video

Updated: Sep 27, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

[TNF-related apoptosis inducing ligand and its research progress on cancer treatment]

X C Wei1, X L Lin, X J Wang

  • 1Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100083.

Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|January 28, 2003
PubMed

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces programmed cell death in tumor cells. This review covers TRAIL

Area of Science:

  • Immunology and Cancer Biology
  • Molecular Biology and Genetics

Background:

  • TRAIL (TNF-related apoptosis-inducing ligand) is a key member of the TNF cytokine superfamily.
  • TRAIL mediates apoptosis, a crucial process for eliminating abnormal cells, including tumor cells.

Purpose of the Study:

  • To review the current research progress on TRAIL.
  • To explore TRAIL's structure, function, and apoptotic pathways.
  • To discuss TRAIL's potential in cancer treatment and future directions.

Main Methods:

  • Literature review and synthesis of existing research on TRAIL.
  • Analysis of TRAIL's molecular mechanisms in inducing apoptosis.
  • Examination of preclinical and clinical studies involving TRAIL for cancer therapy.

Main Results:

  • TRAIL effectively induces apoptosis in numerous cancer cell lines.
  • Understanding TRAIL's signaling pathways is crucial for therapeutic development.
  • TRAIL-based therapies show promise but face challenges in clinical application.

Conclusions:

  • TRAIL is a significant molecule in cancer biology with therapeutic potential.
  • Further research is needed to optimize TRAIL-based cancer treatments.
  • TRAIL's role in apoptosis induction highlights its importance in oncology.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...